Evidence map›Paper›PMID 38614011›Full record

ArticleEBioMedicine2024

Multimodal detection and analysis of microplastics in human thrombi from multiple anatomically distinct sites.

Tingting Wang, Zhiheng Yi, Xiaoqiang Liu, Yuxin Cai, Xianxi Huang, Jingnian Fang, Ronghuai Shen, Weikun Lu, Yingxiu Xiao, Weiduan Zhuang and 1 more

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in EBioMedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
13.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06965023 recruitingnot on this mapstarted 2025, after this paper: background citation

Microplastics and Nanoplastics (MNPs) in Patients With ST-elevation Myocardial Infarction (STEMI)

TypeobservationalSponsorAzienda Ospedaliera "Sant'Andrea"Ran2025 to 2027Enrolled130ConditionsST-elevation Myocardial Infarction (STEMI), Microplastics, Nanoplastics, Pollution Exposure
NCT07291609 recruitingnot on this mapstarted 2025, after this paper: background citation

Microplastics and Nanoplastics in Patients With Chronic Coronary Syndromes

Typeobservational_patient_registrySponsorAzienda Ospedaliera "Sant'Andrea"Ran2025 to 2029Enrolled120ConditionsChronic Coronary Syndrome, Microplastics, Nanoplastics, Coronary Artery Disease
3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it, 101 citations in OpenAlex.

  1. Health impacts of micro- and nanoplastics in humans: systematic review of in vivo evidence.Environmental health : a global access science source · 2026
    Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Tingting WangDepartment of Neurology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Zhiheng YiDepartment of Neurology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Xiaoqiang LiuDepartment of Neurology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Yuxin CaiIntervention Department, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Xianxi HuangDepartment of Cardiology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Jingnian FangDepartment of Neurology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Ronghuai ShenDepartment of Cardiology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Weikun LuDepartment of Neurology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Yingxiu XiaoDepartment of Neurology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Weiduan ZhuangDepartment of Neurology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China. Electronic address: zhuangweiduan@sina.cn.
Shaowei GuoDepartment of Neurology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China. Electronic address: 07swguo1@stu.edu.cn.
Shantou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMicroplastic (MP) pollution has emerged as a significant environmental concern worldwide. While extensive research has focused on their presence in marine organisms and ecosystems, their potential impact on human health, particularly on the circulatory system, remains understudied. This project aimed to identify and quantify the mass concentrations, polymer types, and physical properties of MPs in human thrombi surgically retrieved from both arterial and venous systems at three anatomically distinct sites, namely, cerebral arteries in the brain, coronary arteries in the heart, and deep veins in the lower extremities. Furthermore, this study aimed to investigate the potential association between the levels of MPs and disease severity.

methodsThrombus samples were collected from 30 patients who underwent thrombectomy procedures due to ischaemic stroke (IS), myocardial infarction (MI), or deep vein thrombosis (DVT). Pyrolysis-gas chromatography mass spectrometry (Py-GC/MS) was employed to identify and quantify the mass concentrations of the MPs. Laser direct infrared (LDIR) spectroscopy and scanning electron microscopy (SEM) were used to analyse the physical properties of the MPs. Demographic and clinical information were also examined. A rigorous quality control system was used to eliminate potential environmental contamination.

findingsMPs were detected by Py-GC/MS in 80% (24/30) of the thrombi obtained from patients with IS, MI, or DVT, with median concentrations of 61.75 μg/g, 141.80 μg/g, and 69.62 μg/g, respectively. Among the 10 target types of MP polymers, polyamide 66 (PA66), polyvinyl chloride (PVC), and polyethylene (PE) were identified. Further analyses suggested that higher concentrations of MPs may be associated with greater disease severity (adjusted β = 7.72, 95% CI: 2.01-13.43, p < 0.05). The level of D-dimer in the MP-detected group was significantly higher than that in the MP-undetected group (8.3 ± 1.5 μg/L vs 6.6 ± 0.5 μg/L, p < 0.001). Additionally, LDIR analysis showed that PE was dominant among the 15 types of identified MPs, accounting for 53.6% of all MPs, with a mean diameter of 35.6 μm. The shapes of the polymers detected using LDIR and SEM were found to be heterogeneous.

interpretationThis study presents both qualitative and quantitative evidence of the presence of MPs, and their mass concentrations, polymer types, and physical properties in thrombotic diseases through the use of multimodal detection methods. Higher concentrations of MPs may be associated with increased disease severity. Future research with a larger sample size is urgently needed to identify the sources of exposure and validate the observed trends in the study.

fundingThis study was funded by the SUMC Scientific Research Initiation Grant (SRIG, No. 009-510858038), Postdoctoral Research Initiation Grant (No. 202205230031-3), and the 2020 Li Ka Shing Foundation Cross-Disciplinary Research Grant (No. 2020LKSFG02C).

Indexed as

MicroplasticsThrombosisAdultAgedAged, 80 and overFemaleGas Chromatography-Mass SpectrometryHumansMaleMiddle AgedMicroplasticsDeep vein thrombosisMicroplasticsMyocardial infarctionPy-GC/MSStrokeThrombus

Identifiers

PMID38614011
PMCPMC11021838
OpenAlexW4394789036

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.